Clinuvel Pharmaceuticals (Clinuvel Pharmaceuticals) Days Sales Outstanding : 96.01 (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Clinuvel Pharmaceuticals Days Sales Outstanding?

Clinuvel Pharmaceuticals's average Accounts Receivable for the six months ended in Dec. 2023 was $11.36 Mil. Clinuvel Pharmaceuticals's Revenue for the six months ended in Dec. 2023 was $21.59 Mil. Hence, Clinuvel Pharmaceuticals's Days Sales Outstanding for the six months ended in Dec. 2023 was 96.01.

The historical rank and industry rank for Clinuvel Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

CLVLF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 51.12 Med: 84.92 Max: 159
Current: 66.73

During the past 13 years, Clinuvel Pharmaceuticals's highest Days Sales Outstanding was 159.00. The lowest was 51.12. And the median was 84.92.

CLVLF's Days Sales Outstanding is ranked better than
53.09% of 889 companies
in the Biotechnology industry
Industry Median: 71.83 vs CLVLF: 66.73

Clinuvel Pharmaceuticals's Days Sales Outstanding increased from Dec. 2022 (84.62) to Dec. 2023 (96.01).

Clinuvel Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Clinuvel Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinuvel Pharmaceuticals Days Sales Outstanding Chart

Clinuvel Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Sales Outstanding

Get a 7-Day Free Trial

53.42

56.78

81.95

91.91

87.27

Clinuvel Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															100.00	58.12	84.62	58.76	96.01

Competitive Comparison of Clinuvel Pharmaceuticals's Days Sales Outstanding

For the Biotechnology subindustry, Clinuvel Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clinuvel Pharmaceuticals's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clinuvel Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Clinuvel Pharmaceuticals's Days Sales Outstanding falls into.

Clinuvel Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Clinuvel Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (11.172	+	13.965)	/	2 )	/	52.564	*	365
=	12.5685					/	52.564	*	365
=	87.27

Clinuvel Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (13.965	+	8.752)	/	2 )	/	21.591	*	365 / 2
=	11.3585					/	21.591	*	365 / 2
=	96.01

Clinuvel Pharmaceuticals (OTCPK:CLVLF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Clinuvel Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Clinuvel Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Clinuvel Pharmaceuticals (Clinuvel Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clinuvel Pharmaceuticals Ltd (OTCPK:CLVLF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

CLVLY:USA UR9:Germany CUV:Australia

Address

535 Bourke Street, Level 11, Melbourne, VIC, AUS, 3000

Website

https://www.clinuvel.com

Clinuvel distributes a single-product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the U.S.